Breaking Down 111, Inc. (YI) Financial Health: Key Insights for Investors

Breaking Down 111, Inc. (YI) Financial Health: Key Insights for Investors

CN | Healthcare | Medical - Pharmaceuticals | NASDAQ

111, Inc. (YI) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Are you keeping a close watch on your investments in the healthcare sector? Have you been following 111, Inc. (YI), a key player in China's tech-enabled healthcare? The company's 2024 financial results are now available, revealing some significant shifts. While net revenues decreased by 3.7% to RMB 14.4 billion (US$2.0 billion), the company achieved its first-ever annual operating profit of RMB 2.1 million (US$0.3 million), a substantial turnaround from a loss of RMB 350.1 million in 2023. Want to know how 111, Inc. managed this impressive feat and what it means for investors? Keep reading to explore the critical insights.

111, Inc. (YI) Revenue Analysis

To understand the financial health of 111, Inc. (YI), a detailed revenue analysis is essential. This involves examining the company's primary revenue sources, year-over-year growth rates, the contribution of different business segments, and any significant changes in its revenue streams.

Based on the latest available information, here's a breakdown of 111, Inc.'s revenue streams:

  • Primary Revenue Sources: 111, Inc. primarily generates revenue through its online retail pharmacy and healthcare services platform. This includes sales of pharmaceutical products, medical devices, and healthcare-related services.
  • Year-over-Year Revenue Growth Rate: Analyzing historical trends in revenue growth provides insights into the company's performance. Investors should consider the percentage increase or decrease in revenue from year to year to assess the company's growth trajectory.
  • Contribution of Business Segments: A breakdown of revenue by business segment reveals the relative importance of each segment to the company's overall revenue. This may include online retail, wholesale, and other healthcare service offerings.
  • Significant Changes in Revenue Streams: Investors should be aware of any significant changes in the company's revenue streams, such as the introduction of new products or services, expansion into new markets, or shifts in consumer demand.

To provide a clearer picture, here's an example of how revenue data might be presented (Note: This is for illustrative purposes, and you should refer to the latest financial reports for actual data):

Revenue Source 2022 (USD) 2023 (USD) 2024 (USD)
Online Retail 50 million 60 million 70 million
Wholesale 30 million 35 million 40 million
Healthcare Services 20 million 25 million 30 million
Total Revenue 100 million 120 million 140 million

Analyzing these components helps investors gain a comprehensive understanding of how 111, Inc. generates revenue and identify potential opportunities and risks. For further insights, you can explore: Breaking Down 111, Inc. (YI) Financial Health: Key Insights for Investors

Understanding these elements is crucial for a thorough assessment of 111, Inc.'s financial position and future prospects.

111, Inc. (YI) Profitability Metrics

Analyzing 111, Inc.'s profitability involves examining its gross profit, operating profit, and net profit margins to understand its financial health and operational efficiency. Trends in these metrics over time provide insights into the company's ability to manage costs and generate profits. Comparing these ratios with industry averages helps contextualize 111, Inc.'s performance.

For the fiscal year 2024, detailed financial figures are essential to accurately assess 111, Inc.'s profitability. However, based on the latest available data, we can provide an overview of key profitability aspects.

Gross Profit: Gross profit is a critical indicator of a company's efficiency in managing its cost of goods sold (COGS). A higher gross profit margin indicates that 111, Inc. effectively controls its production costs and pricing strategies. For instance, if 111, Inc. reported a gross profit of $XX million with revenues of $YY million, the gross profit margin would be (XX/YY)100%.

Operating Profit: Operating profit reflects a company's earnings from its core business operations, excluding interest and taxes. It is calculated by deducting operating expenses (such as sales, general, and administrative expenses) from the gross profit. A rising operating profit margin suggests improved operational efficiency. If 111, Inc.'s operating profit was $AA million, the operating profit margin would be (AA/YY)100%, where $YY million is the revenue.

Net Profit: Net profit, often referred to as the bottom line, represents the actual profit the company earns after all expenses, including interest and taxes, are paid. The net profit margin is a key indicator of overall financial health. For example, if 111, Inc. reported a net profit of $BB million, the net profit margin would be (BB/YY)100%, where $YY million represents the total revenue.

To provide a clearer picture, let's consider a hypothetical scenario based on available information:

Metric Amount (USD Millions) Margin (%)
Revenue YY N/A
Gross Profit XX (XX/YY)100%
Operating Profit AA (AA/YY)100%
Net Profit BB (BB/YY)100%

Trends in Profitability Over Time: Analyzing profitability trends over several periods (e.g., quarterly or annually) is crucial. Consistent growth in profit margins indicates strong financial management and market positioning. Conversely, declining margins may signal challenges such as increased competition, rising costs, or inefficient operations.

Comparison with Industry Averages: Comparing 111, Inc.'s profitability ratios with industry averages provides valuable context. If 111, Inc.'s gross profit margin is 30% while the industry average is 25%, it suggests that the company is performing well in managing its cost of goods sold compared to its peers.

Analysis of Operational Efficiency: Operational efficiency is closely tied to profitability. Key areas to examine include:

  • Cost Management: Effective cost management directly impacts profitability. Analyzing how 111, Inc. controls its operating expenses and COGS can reveal insights into its efficiency.
  • Gross Margin Trends: Monitoring gross margin trends helps identify whether the company is improving its production and pricing strategies over time.

Understanding these profitability metrics and trends is essential for investors and stakeholders to assess 111, Inc.'s financial performance and make informed decisions.

More insights are available here: Breaking Down 111, Inc. (YI) Financial Health: Key Insights for Investors

111, Inc. (YI) Debt vs. Equity Structure

Understanding how 111, Inc. (YI) finances its operations is crucial for investors. This involves looking at the company's debt levels, its debt-to-equity ratio, and how it balances debt and equity funding. Here’s a breakdown:

As of September 2024, 111, Inc.'s total debt was reported at approximately S$43.46 million.

Key points regarding 111, Inc.'s debt and equity:

  • Debt-to-Equity Ratio: As of December 30, 2024, the debt-to-equity ratio was 42.3%. This ratio is a measure of a company's financial leverage, calculated by dividing its total debt by shareholders' equity.
  • Shareholder Equity and Total Debt: 111, Inc. has a total shareholder equity of CN¥380.8 million and a total debt of CN¥161.0 million.
  • Long-Term Debt: The debt/equity ratio for the three months ending September 30, 2024, was 0.00.

To gain more insight into 111, Inc. (YI), consider reading: Exploring 111, Inc. (YI) Investor Profile: Who’s Buying and Why?

The following table summarizes key financial strength metrics for 111, Inc. (YI):

Metric YI
Quick Ratio 0.41
Current Ratio 1.09
Interest Coverage -6.71

In fiscal year 2024, 111, Inc. achieved its first-ever annual operating profit. Income from operations was RMB2.1 million (US$0.3 million), a significant improvement from the loss from operations of RMB350.1 million in 2023. Non-GAAP income from operations was RMB22.3 million (US$3.0 million), compared to a non-GAAP loss of RMB123.9 million in the previous year. The company also achieved its first-ever positive operating cash flow, with net cash from operating activities reaching RMB263.0 million (US$36.0 million).

111, Inc. held cash and cash equivalents, restricted cash, and short-term investments totaling RMB518.3 million (US$71.0 million) as of December 31, 2024, compared to RMB673.7 million as of December 31, 2023.

In Q1 2024, 111, Inc. had a total outstanding amount of RMB1.1 billion owed to investors of 1 Pharmacy Technology, related to equity investments made in 2020. Redemption requests from certain investors totaled RMB0.2 billion.

Overall, 111, Inc. is navigating its debt and equity structure while striving for profitability and improved financial health. The company's efforts to reduce operating expenses and achieve positive operating cash flow are noteworthy.

111, Inc. (YI) Liquidity and Solvency

When evaluating the financial health of 111, Inc. (YI), understanding its liquidity and solvency is crucial. Liquidity refers to the company's ability to meet its short-term obligations, while solvency indicates its ability to meet long-term obligations. Let's delve into key financial metrics to assess 111, Inc.'s financial stability.

Assessing 111, Inc.'s Liquidity:

Liquidity ratios provide insights into a company's ability to cover its short-term liabilities with its short-term assets. Two key ratios to consider are the current ratio and the quick ratio.

  • Current Ratio: The current ratio is calculated by dividing current assets by current liabilities. A higher current ratio generally indicates better liquidity.
  • Quick Ratio: The quick ratio, also known as the acid-test ratio, is calculated by dividing quick assets (current assets less inventory) by current liabilities. This ratio provides a more conservative measure of liquidity, as it excludes inventory, which may not be easily converted into cash.

Analysis of working capital trends is also vital. Working capital is the difference between a company's current assets and current liabilities. Monitoring changes in working capital can reveal whether a company's short-term financial health is improving or deteriorating.

Cash Flow Statements Overview:

Cash flow statements provide a comprehensive view of a company's cash inflows and outflows. Analyzing the trends in operating, investing, and financing cash flows can offer valuable insights into a company's liquidity position.

  • Operating Cash Flow: Cash generated from the company's core business activities.
  • Investing Cash Flow: Cash flow related to the purchase and sale of long-term assets.
  • Financing Cash Flow: Cash flow related to debt, equity, and dividends.

Monitoring these cash flow trends can help identify any potential liquidity concerns or strengths. For example, consistently negative operating cash flow may indicate that a company is struggling to generate cash from its core operations, which could lead to liquidity issues.

Here is a sample table illustrating the cash flow trends:

Category 2022 (USD) 2023 (USD) 2024 (USD)
Operating Cash Flow -10,000,000 -8,000,000 -6,000,000
Investing Cash Flow -2,000,000 -1,500,000 -1,000,000
Financing Cash Flow 12,000,000 9,500,000 7,000,000

For further insights into the investors of 111, Inc. (YI), consider exploring: Exploring 111, Inc. (YI) Investor Profile: Who’s Buying and Why?

111, Inc. (YI) Valuation Analysis

Determining whether 111, Inc. (YI) is overvalued or undervalued requires a multifaceted approach, incorporating key financial ratios, stock performance analysis, and analyst sentiment. This comprehensive evaluation provides investors with a clearer picture of the company's intrinsic value relative to its current market price. For additional insights, you might find this resource helpful: Breaking Down 111, Inc. (YI) Financial Health: Key Insights for Investors.

To assess 111, Inc.'s (YI) valuation, several key financial ratios are essential:

  • Price-to-Earnings (P/E) Ratio: This ratio compares the company's stock price to its earnings per share. A higher P/E ratio might suggest overvaluation, while a lower ratio could indicate undervaluation, relative to industry peers.
  • Price-to-Book (P/B) Ratio: The P/B ratio measures the market's valuation of a company relative to its book value. A lower P/B ratio can suggest the stock is undervalued.
  • Enterprise Value-to-EBITDA (EV/EBITDA): This ratio compares the company's enterprise value to its earnings before interest, taxes, depreciation, and amortization. It provides a more comprehensive valuation measure, especially useful for comparing companies with different capital structures.

Analyzing 111, Inc.'s (YI) stock price trends over the past 12 months, or longer, can reveal important insights into market sentiment and investor confidence. Significant price appreciation might indicate growing optimism, while a declining trend could signal concerns about the company's future prospects.

As of April 2025, dividend yield and payout ratios are not applicable for 111, Inc. (YI), as the company does not currently offer dividends.

Here is a table summarizing potential valuation considerations for 111, Inc. (YI):

Valuation Metric Description Relevance to 111, Inc. (YI)
P/E Ratio Compares stock price to earnings per share Useful for relative valuation against peers
P/B Ratio Measures market valuation relative to book value Indicates if the stock is undervalued based on assets
EV/EBITDA Enterprise value relative to earnings before interest, taxes, depreciation, and amortization Comprehensive valuation measure
Stock Price Trend Stock price movement over time Reflects market sentiment and investor confidence
Dividend Yield Dividend payout as a percentage of stock price Not applicable as 111, Inc. (YI) does not offer dividends

Analyst consensus on 111, Inc.'s (YI) stock valuation, categorized as buy, hold, or sell recommendations, reflects the collective opinion of financial analysts. These ratings can significantly influence investor decisions and market perception of the stock.

111, Inc. (YI) Risk Factors

Understanding the risks that 111, Inc. (YI) faces is crucial for investors. These risks can be both internal and external, significantly impacting the company's financial health and future prospects. Key areas of concern include industry competition, regulatory changes, and overall market conditions.

Here's an overview of the primary risks:

  • Industry Competition: The online retail and healthcare sectors are intensely competitive. 111, Inc. faces competition from established e-commerce giants, traditional pharmacies, and other online healthcare platforms. Maintaining a competitive edge requires continuous innovation, effective marketing, and superior customer service.
  • Regulatory Changes: The pharmaceutical and healthcare industries are heavily regulated. Changes in regulations related to online pharmacies, drug pricing, and healthcare services can significantly impact 111, Inc.'s operations and financial results. Compliance with evolving regulations requires ongoing investment in legal and compliance resources.
  • Market Conditions: Economic downturns, changes in consumer spending habits, and fluctuations in the demand for healthcare products and services can affect 111, Inc.'s revenue and profitability. Monitoring macroeconomic trends and adapting business strategies accordingly is essential.

Operational, financial, and strategic risks are often detailed in the company's earnings reports and filings. These reports provide insights into specific challenges and uncertainties that 111, Inc. is currently navigating.

Examples of such risks may include:

  • Supply Chain Disruptions: Disruptions to the supply chain, whether due to natural disasters, geopolitical events, or other factors, can impact the availability of products and increase costs. Diversifying supply sources and implementing robust inventory management practices are crucial mitigation strategies.
  • Cybersecurity Threats: As an online platform, 111, Inc. is vulnerable to cybersecurity threats, including data breaches and hacking attempts. Investing in cybersecurity infrastructure and protocols is essential to protect sensitive customer data and maintain trust.
  • Financial Risks: These can include fluctuations in currency exchange rates, changes in interest rates, and the availability of financing. Implementing hedging strategies and maintaining a strong balance sheet can help mitigate these risks.

Mitigation strategies are crucial for addressing these risks. While specific plans may vary, common strategies include:

  • Diversification: Expanding into new markets, product categories, and service offerings can reduce reliance on any single area of the business.
  • Technology Investment: Investing in technology to improve efficiency, enhance customer experience, and strengthen cybersecurity defenses.
  • Strategic Partnerships: Collaborating with other companies to expand reach, access new technologies, and share resources.

Understanding 111, Inc.'s mission, vision, and core values can provide additional context for assessing its strategic direction and risk management approach. More information is available at: Mission Statement, Vision, & Core Values of 111, Inc. (YI).

111, Inc. (YI) Growth Opportunities

For investors eyeing 111, Inc. (YI), a clear understanding of its potential growth avenues is essential. This encompasses dissecting the catalysts for growth, such as pioneering products, extending market reach, strategic acquisitions, forecasting revenue and earnings, and pinpointing the competitive edges that bolster the company's growth trajectory. A comprehensive analysis reveals both the promise and the challenges that lie ahead for 111, Inc. (YI).

Analyzing 111, Inc.'s (YI) growth prospects requires a multifaceted approach, focusing on several key drivers:

  • Product Innovations: Evaluating the impact of new products and services on revenue.
  • Market Expansion: Assessing the potential of entering new geographic or demographic markets.
  • Acquisitions: Examining the strategic benefits and financial impact of recent and potential acquisitions.

Predicting future financial performance is crucial. While specific figures for 2024-2025 are not available, understanding the factors influencing revenue and earnings is key. Investors should monitor:

  • Revenue Growth Projections: Analyzing market trends and company strategies to project sales increases.
  • Earnings Estimates: Assessing profitability based on cost management and revenue growth.

Strategic initiatives and partnerships can significantly influence 111, Inc.'s (YI) growth trajectory. These include:

  • Partnerships: Evaluating the impact of collaborations on market reach and product development.
  • Strategic Initiatives: Assessing the effectiveness of company-led projects aimed at growth and efficiency.

Competitive advantages are vital for sustained growth. Key factors to consider include:

  • Technological Edge: Assessing the company's ability to innovate and leverage technology.
  • Brand Reputation: Evaluating the strength of the brand and its impact on customer loyalty.
  • Operational Efficiency: Analyzing how effectively the company manages its costs and resources.

To provide a clearer picture, here's a hypothetical projection framework based on available information and industry trends. Please note that these figures are speculative and for illustrative purposes only.

Category 2023 (Actual) 2024 (Projected) 2025 (Projected)
Revenue (USD millions) 250 275 300
Earnings per Share (EPS) 0.50 0.55 0.60
Market Expansion Rate 5% 6% 7%

These projections are contingent on various factors, including market conditions, the successful execution of strategic initiatives, and the competitive landscape. Investors should conduct thorough due diligence and stay informed about the latest developments concerning 111, Inc. (YI) to make well-informed decisions.

For a deeper dive into 111, Inc. (YI) financial health, consider exploring: Breaking Down 111, Inc. (YI) Financial Health: Key Insights for Investors

DCF model

111, Inc. (YI) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.